PSMJX
Price
$9.61
Change
-$0.74 (-7.15%)
Updated
Apr 3 closing price
Net Assets
1.07B
VSCAX
Price
$20.55
Change
-$1.97 (-8.75%)
Updated
Apr 3 closing price
Net Assets
6.34B
Ad is loading...

PSMJX vs VSCAX

Header iconPSMJX vs VSCAX Comparison
Open Charts PSMJX vs VSCAXBanner chart's image
Principal SmallCap Value II J
Price$9.61
Change-$0.74 (-7.15%)
VolumeN/A
Net Assets1.07B
Invesco Small Cap Value A
Price$20.55
Change-$1.97 (-8.75%)
VolumeN/A
Net Assets6.34B
PSMJX vs VSCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PSMJX vs. VSCAX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSMJX is a Hold and VSCAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 6.35B vs. PSMJX (1.07B). PSMJX pays higher dividends than VSCAX: PSMJX (1.19) vs VSCAX (0.37). PSMJX was incepted earlier than VSCAX: PSMJX (16 years) vs VSCAX (26 years). PSMJX (1.36) is less costly to investors than VSCAX (1.12). PSMJX is a more actively managed with annual turnover of: 73.90 vs. VSCAX (40.00). PSMJX (1000) and VSCAX (1000) have matching initial minimum investment requirements. VSCAX annual gain was more profitable for investors over the last year : -1.20 vs. PSMJX (-11.65). VSCAX return over 5 years is better than : 216.20 vs. PSMJX (69.77).
PSMJXVSCAXPSMJX / VSCAX
Total Expense Ratio1.341.12120%
Annual Report Gross Expense Ratio1.361.12121%
Fund Existence16 years26 years-
Gain YTD-5.479-4.211130%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B6.35B17%
Annual Yield % from dividends1.190.37326%
Returns for 1 year-11.65-1.20968%
Returns for 3 years-13.2113.84-95%
Returns for 5 years69.77216.2032%
Returns for 10 years-18.659.77-191%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX12.85N/A
N/A
ICON Health and Information Tech Inv
BRXSX13.75N/A
N/A
MFS Blended Research Intl Eq R2
DGEYX20.42N/A
N/A
BNY Mellon Global Emerging Mkts - Y
GAOTX20.20N/A
N/A
JPMorgan Global Allocation R3
CBFFX36.62-0.68
-1.82%
American Funds Global Balanced 529F1